UBS raised the firm’s price target on Ovintiv (OVV) to $54 from $52 and keeps a Buy rating on the shares. Ovintiv is on a clear path for valuation creation, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVV:
- Ovintiv price target lowered to $52 from $54 at Citi
- Ovintiv price target raised to $42 from $38 at Wells Fargo
- Nuvista Energy downgraded to Hold from Buy at Jefferies
- Nuvista Energy downgraded to Market Perform from Outperform at BMO Capital
- Ovintiv Announces Acquisition Agreement with NuVista Energy